12-Month Results from LivaNova’s OSPREY Clinical Study Published
Full data set demonstrates proximal hypoglossal nerve stimulation yields clinically significant and sustained improvements for patients with moderate to severe OSA.
Full data set demonstrates proximal hypoglossal nerve stimulation yields clinically significant and sustained improvements for patients with moderate to severe OSA.
New launches and upcoming plans from ZOLL Respicardia, Inspire Medical, and LivaNova make patient data more accessible and trackable.